Feed NAGE
NA
Niagen Bioscience Inc
NAGE · NASDAQ
$3.12 +1.63% (+$0.05)
1M -10.60%
Market Cap $242.1M
P/E Ratio 13.93x
Div. Yield -
ROE 25.51%
Bulios Fair Price
$3.48
11.5% upside
Preț actual
$3.12
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile NAGE sunt în prezent subevaluate față de prețul lor de piață. Cum funcționează?
Valuation
77 /100
Cheap P/E 13.93x
PEG 0.13x
EV/EBITDA 11.44x
Growth
100 /100
Growing Rev. growth 21.56%
Book val. growth 38.72%
EPS growth N/A
Profitability
70 /100
Strong Gross margin 64.28%
FCF margin 10.16%
Net margin 13.43%
Quality
93 /100
Excellent ROIC 15.61%
Asset turnover 1.22x
ROE 25.51%
Debt
100 /100
Low Debt/Equity 0.04x
Net debt/EBITDA -3.94x
Current ratio 4.86x
Stability
36 /100
Moderate Beta 2.08x
Profitable years 2
Rev. volatility 7.31%
Întreabă StockBot despre NAGE
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Robert N. Fried
Employees
117
Headquarters
Los Angeles
Evenimente viitoare
03 NOV.
Earnings
Upcoming earnings report